Barat Ali Mashkani (Baratali Mashkani)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Induced Pluripotent Stem Cells

Psychometric Properties

Recombinant Human

Top Venues

Expert review of neurotherapeutics

BioFactors (Oxford, England)

Journal of medical virology

Mashhad University of Medical Sciences

University of Newcastle (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mashhad University of Medical Sciences

Iran

Assistant Prof. :: Medical Biochemistry

Education History

University of Newcastle

Australia

PHD :: Medical Biochemistry

Publications

Mohsen Ghorbanzadeh Neghab, Mohammad Jalili-Nik, Arash Soltani, Amir R Afshari, Seyed Mahdi Hassanian, Houshang Rafatpanah, Seyed Abdolrahim Rezaee, Hamid R Sadeghnia, Sajad Ataei Azimi, Barat Ali Mashkani
Rigosertib is more potent than wortmannin and rapamycin against adult T-cell leukemia-lymphoma. BioFactors (Oxford, England) (2023)
Barat Ali Mashkani, Mohammad Jalili-Nik, Seyed Abdolrahim Rezaee, Reza Boostani
Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy. Expert review of neurotherapeutics (2023)
Mohammad Jalili-Nik, Mohammad Soukhtanloo, Majid Mojarrad, Mohammad Hadi Sadeghian, Barat Ali Mashkani
Challenges of expressing recombinant human tissue factor as a secreted protein in Pichia pastoris . Preparative biochemistry & biotechnology 52 (9) (2022)
Sajad Ehtiati, Masoud Youssefi, Houshang Rafat Panah, Barat Ali Mashkani, Majid Khadem-Rezaiyan, Farnaz Zahedi Avval
Glutathione reductase system changes in HTLV-1 infected patients. Virusdisease 33 (1) (2022)
Neda Yaghoubi, Masoud Youssefi, Seyed Isaac Hashemy, Houshang Rafat Panah, Barat Ali Mashkani, Farnaz Zahedi Avval
Thioredoxin reductase gene expression and activity among human T-cell lymphotropic virus type 1-infected patients. Journal of medical virology 91 (5) (2018)